Guohua Xi Selected Research

Neuroinflammatory Diseases

4/2022	Mechanisms of neuroinflammation in hydrocephalus after intraventricular hemorrhage: a review.
4/2021	Hydrocephalus Following Experimental Subarachnoid Hemorrhage in Rats with Different Aerobic Capacity.
1/2021	Role of lipocalin-2 in extracellular peroxiredoxin 2-induced brain swelling, inflammation and neuronal death.
1/2021	The Role of Thrombin in Brain Injury After Hemorrhagic and Ischemic Stroke.
1/2020	CD47 Blocking Antibody Accelerates Hematoma Clearance After Intracerebral Hemorrhage in Aged Rats.
1/2019	Minocycline attenuates brain injury and iron overload after intracerebral hemorrhage in aged female rats.
6/2016	Role of lipocalin 2 in intraventricular haemoglobin-induced brain injury.
4/2016	Role of Lipocalin-2 in Thrombin-Induced Brain Injury.
9/2015	Role of lipocalin-2 in brain injury after intracerebral hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guohua Xi Research Topics

Disease

96	Cerebral Hemorrhage 05/2024 - 01/2002
76	Brain Injuries (Brain Injury) 11/2023 - 01/2002
55	Brain Edema (Cerebral Edema) 01/2023 - 02/2002
33	Hematoma 01/2023 - 01/2002
23	Hydrocephalus (Hydrocephaly) 04/2024 - 01/2011
21	Hemorrhage 11/2023 - 09/2005
16	Brain Ischemia (Cerebral Ischemia) 08/2023 - 04/2002
13	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2024 - 07/2008
13	Edema (Dropsy) 10/2022 - 02/2002
13	Atrophy 02/2022 - 02/2006
12	Stroke (Strokes) 01/2021 - 02/2004
11	Infarction (Infarctions) 02/2018 - 04/2002
10	Iron Overload 11/2023 - 12/2003
9	Neuroinflammatory Diseases 04/2022 - 09/2015
7	Hemorrhagic Stroke 05/2024 - 01/2013
6	Inflammation (Inflammations) 01/2023 - 01/2006
6	Ischemic Stroke 01/2021 - 02/2009
5	Hypoxia (Hypoxemia) 03/2016 - 06/2002
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2012 - 04/2005
4	Thrombosis (Thrombus) 01/2022 - 12/2002
4	Glioma (Gliomas) 01/2016 - 01/2008
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 01/2003
3	Ischemia 11/2019 - 09/2009
3	Aneurysm (Aneurysms) 11/2016 - 07/2014
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2016 - 08/2014
3	Neurologic Manifestations (Neurological Manifestations) 09/2015 - 02/2004
3	Parkinson Disease (Parkinson's Disease) 11/2007 - 01/2005
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2002
2	Hemolysis 01/2020 - 01/2017
2	Neoplasms (Cancer) 01/2016 - 01/2008
2	Necrosis 01/2011 - 03/2006
2	Hyperglycemia 09/2009 - 04/2007
1	Cognitive Dysfunction 02/2022
1	Weight Loss (Weight Reduction) 01/2021
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2021

Drug/Important Bio-Agent (IBA)

65	IronIBA 05/2024 - 02/2002
42	Thrombin FDA Link 04/2022 - 01/2002
27	Deferoxamine (Desferal)FDA LinkGeneric 08/2023 - 02/2002
26	Hemoglobins (Hemoglobin)IBA 10/2022 - 02/2002
17	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2002
10	Minocycline (Cyclops)FDA LinkGeneric 11/2023 - 03/2009
10	Lipocalin-2IBA 01/2022 - 04/2013
8	Liposomes (Liposome)IBA 04/2024 - 02/2016
8	Clodronic Acid (Clodronate)IBA 04/2024 - 02/2016
7	Ferritins (Ferritin)IBA 01/2021 - 12/2003
7	Peptide Hydrolases (Proteases)FDA Link 12/2016 - 10/2006
7	salicylhydroxamic acid (SHAM)IBA 01/2016 - 04/2005
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2011 - 01/2002
6	Heme Oxygenase-1IBA 10/2021 - 12/2003
6	PeroxiredoxinsIBA 01/2021 - 01/2020
6	Chelating AgentsIBA 01/2019 - 02/2002
5	Complement System Proteins (Complement)IBA 04/2022 - 07/2005
5	Thrombin Receptors (Thrombin Receptor)IBA 01/2016 - 04/2002
4	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2023 - 01/2016
4	Estrogens (Estrogen)FDA Link 01/2022 - 07/2005
4	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 04/2007
4	Oxygen (Dioxygen)IBA 02/2018 - 04/2007
3	CytokinesIBA 04/2022 - 03/2009
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2011
3	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2011
3	PlatinumIBA 11/2016 - 07/2014
3	EnzymesIBA 03/2016 - 01/2016
3	Heme (Haem)IBA 01/2016 - 12/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 03/2006
3	Mitogen-Activated Protein KinasesIBA 01/2013 - 09/2009
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013 - 11/2004
3	Messenger RNA (mRNA)IBA 01/2013 - 01/2002
3	Collagenases (Collagenase)FDA Link 06/2011 - 12/2002
3	argatroban (MPQA)FDA Link 01/2008 - 12/2002
3	Oxidopamine (6 Hydroxydopamine)IBA 11/2007 - 01/2005
3	Transferrin (beta 2 Transferrin)IBA 02/2005 - 12/2003
2	Aurintricarboxylic AcidIBA 11/2023 - 01/2019
2	AlbuminsIBA 01/2021 - 01/2013
2	Complement C3 (C3 Complement)IBA 01/2021 - 12/2006
2	Hemin (Panhematin)FDA Link 01/2019 - 01/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2016 - 01/2009
2	Neuroprotective AgentsIBA 11/2016 - 01/2011
2	Estrogen ReceptorsIBA 01/2016 - 07/2005
2	Tamoxifen FDA LinkGeneric 01/2016 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 09/2009
2	Fulvestrant (Faslodex)FDA Link 01/2016 - 07/2005
2	ImmunosorbentsIBA 01/2016 - 01/2016
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2011 - 01/2009
2	Evans Blue (Blue, Evans)FDA Link 01/2011 - 04/2007
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2009 - 05/2007
2	Complement C5 (Complement 5)IBA 12/2006 - 05/2004
2	HirudinsIBA 02/2004 - 01/2002
2	Transferrin Receptors (Transferrin Receptor)IBA 12/2003 - 12/2003
1	Biomarkers (Surrogate Marker)IBA 05/2024
1	enhanced green fluorescent proteinIBA 11/2022
1	NeurotoxinsIBA 10/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Laminin (Merosin)IBA 01/2022
1	Myelin Basic ProteinIBA 10/2021
1	Prothrombin (Factor II)IBA 01/2021

Therapy/Procedure

17	Therapeutics 08/2023 - 12/2002
9	Intraventricular Injections 11/2023 - 03/2014
2	Injections 08/2021 - 01/2021
2	Minimally Invasive Surgical Procedures 01/2020 - 01/2018
2	Catheters 01/2018 - 07/2002